These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7309132)

  • 1. Induction of experimental autoimmune diabetes by low-dose streptozotocin treatment in genetically resistant mice.
    Kiesel U; Greulich B; Moumé CM; Kolb H
    Immunol Lett; 1981 Oct; 3(4):227-30. PubMed ID: 7309132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of low-dose streptozotocin-induced autoimmune diabetes in mice.
    Kiesel U; Falkenberg FW; Kolb H
    J Immunol; 1983 Apr; 130(4):1719-22. PubMed ID: 6833751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin.
    Zdravkovic N; Shahin A; Arsenijevic N; Lukic ML; Mensah-Brown EP
    Mol Immunol; 2009 Nov; 47(1):28-36. PubMed ID: 19356801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.
    Leiter EH
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):630-4. PubMed ID: 6210909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
    Elias D; Marcus H; Reshef T; Ablamunits V; Cohen IR
    Eur J Immunol; 1995 Oct; 25(10):2851-7. PubMed ID: 7589082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in naive and cyclosporin-treated low-responder murine strains.
    Wright JR; Fraser RB; Kapoor S; Cook HW
    Acta Diabetol; 1995 Jun; 32(2):125-30. PubMed ID: 7579534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose streptozotocin-induced autoimmune diabetes is under the genetic control of the major histocompatibility complex in mice.
    Kiesel U; Kolb H
    Diabetologia; 1982 Jul; 23(1):69-71. PubMed ID: 6214445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.
    Zunino SJ; Simons LF; Sambrook JF; Gething MJ
    Am J Pathol; 1994 Sep; 145(3):661-70. PubMed ID: 8080048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single major gene controls most of the difference in susceptibility to streptozotocin-induced diabetes between C57BL/6J and C3H/HeJ mice.
    Kaku K; McGill J; Province M; Permutt MA
    Diabetologia; 1989 Oct; 32(10):716-23. PubMed ID: 2574118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose streptozotocin-induced diabetes in mice: reduced IL-2 production and modulation of streptozotocin-induced hyperglycemia by IL-2.
    Burkart V; Zielasek J; Kantwerk-Funke G; Hibbe T; Schwab E; Kolb H
    Int J Immunopharmacol; 1992 Aug; 14(6):1037-44. PubMed ID: 1428358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes susceptibility of BALB/cBOM mice treated with streptozotocin. Inhibition by lethal irradiation and restoration by splenic lymphocytes.
    Paik SG; Blue ML; Fleischer N; Shin S
    Diabetes; 1982 Sep; 31(9):808-15. PubMed ID: 6219023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin.
    Elias D; Prigozin H; Polak N; Rapoport M; Lohse AW; Cohen IR
    Diabetes; 1994 Aug; 43(8):992-8. PubMed ID: 8039607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens.
    Paik SG; Michelis MA; Kim YT; Shin S
    Diabetes; 1982 Aug; 31(8 Pt 1):724-9. PubMed ID: 6219020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased atherosclerosis in streptozotocin-induced diabetic mice.
    Kunjathoor VV; Wilson DL; LeBoeuf RC
    J Clin Invest; 1996 Apr; 97(7):1767-73. PubMed ID: 8601643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia in BALB/c mice after pretreatment with one subdiabetogenic dose of streptozotocin and subsequent infection with a Coxsackie B4 strain.
    Wegner U; Kewitsch A; Madauss M; Döhner L; Zühlke H
    Biomed Biochim Acta; 1985; 44(1):21-7. PubMed ID: 2986611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
    Ablamunits V; Quintana F; Reshef T; Elias D; Cohen IR
    J Autoimmun; 1999 Dec; 13(4):383-92. PubMed ID: 10585754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of hyperglycaemia on the immune response in an experimental model of diabetes in BALB/cByJ and C57Bl/6J mice: participation of oxidative stress.
    Rubinstein MR; Genaro AM; Wald MR
    Clin Exp Immunol; 2013 Mar; 171(3):319-29. PubMed ID: 23379439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypoinsulinemia, hyperglycemia and circulating antibodies to the islet cells during the development of streptozotocin diabetes in rats].
    Pankov IuA; Kondrat'ev IaIu; Gorskova VA; Keda IuM; Osipova TA; Arbuzova MI; Sadovnikova NV; Fedotov VP
    Probl Endokrinol (Mosk); 1990; 36(2):70-3. PubMed ID: 2194204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of microencapsulated rat islets implanted in different diabetic models in mice.
    Darquy S; Chicheportiche D; Capron F; Boitard C; Reach G
    Horm Metab Res Suppl; 1990; 25():209-13. PubMed ID: 2088971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of genetic background on the susceptibility of inbred mice to streptozotocin-induced diabetes.
    Wolf J; Lilly F; Shin SI
    Diabetes; 1984 Jun; 33(6):567-71. PubMed ID: 6233198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.